Cognex Corporation (NASDAQ:CGNX - Get Free Report) VP Laura Ann Macdonald sold 41,600 shares of the company's stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $65.56, for a total value of $2,727,296.00. Following the transaction, the vice president directly owned 5,258 shares in the company, valued at $344,714.48. This represents a 88.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Laura Ann Macdonald also recently made the following trade(s):
- On Monday, May 11th, Laura Ann Macdonald sold 98,122 shares of Cognex stock. The stock was sold at an average price of $66.80, for a total value of $6,554,549.60.
- On Thursday, February 12th, Laura Ann Macdonald sold 14,881 shares of Cognex stock. The stock was sold at an average price of $57.16, for a total value of $850,597.96.
Cognex Stock Down 2.3%
CGNX stock traded down $1.58 on Tuesday, reaching $65.68. 2,359,419 shares of the company's stock were exchanged, compared to its average volume of 2,228,531. The stock has a fifty day moving average of $53.08 and a 200-day moving average of $45.47. Cognex Corporation has a twelve month low of $29.00 and a twelve month high of $71.90. The firm has a market cap of $10.93 billion, a PE ratio of 78.19 and a beta of 1.48.
Cognex (NASDAQ:CGNX - Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.09. Cognex had a return on equity of 10.89% and a net margin of 13.62%.The firm had revenue of $268.44 million for the quarter, compared to analyst estimates of $245.98 million. During the same quarter in the prior year, the company posted $0.14 earnings per share. Cognex's quarterly revenue was up 24.3% on a year-over-year basis. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. On average, equities research analysts predict that Cognex Corporation will post 0.97 EPS for the current fiscal year.
Cognex Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 4th. Investors of record on Thursday, May 21st will be issued a dividend of $0.085 per share. This represents a $0.34 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Thursday, May 21st. Cognex's dividend payout ratio is currently 40.48%.
Institutional Trading of Cognex
A number of institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in shares of Cognex by 2.1% in the third quarter. Vanguard Group Inc. now owns 18,598,728 shares of the scientific and technical instruments company's stock valued at $842,522,000 after acquiring an additional 374,999 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in shares of Cognex by 173,138.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 10,477,448 shares of the scientific and technical instruments company's stock valued at $376,979,000 after acquiring an additional 10,471,400 shares in the last quarter. Nordea Investment Management AB lifted its position in shares of Cognex by 0.9% in the fourth quarter. Nordea Investment Management AB now owns 8,101,583 shares of the scientific and technical instruments company's stock valued at $292,224,000 after acquiring an additional 76,212 shares in the last quarter. Pictet Asset Management Holding SA lifted its position in shares of Cognex by 27.9% in the fourth quarter. Pictet Asset Management Holding SA now owns 7,013,184 shares of the scientific and technical instruments company's stock valued at $252,360,000 after acquiring an additional 1,529,010 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its position in shares of Cognex by 31.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,314,896 shares of the scientific and technical instruments company's stock valued at $191,231,000 after acquiring an additional 1,258,629 shares in the last quarter. 88.12% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
CGNX has been the topic of a number of research analyst reports. DA Davidson set a $55.00 target price on Cognex and gave the stock a "neutral" rating in a research report on Tuesday, February 17th. TD Cowen reiterated a "buy" rating on shares of Cognex in a research report on Tuesday, February 17th. JPMorgan Chase & Co. boosted their target price on Cognex from $55.00 to $65.00 and gave the stock a "neutral" rating in a research report on Friday. Raymond James Financial reiterated a "strong-buy" rating on shares of Cognex in a research report on Thursday, February 12th. Finally, Sanford C. Bernstein reiterated an "outperform" rating and set a $75.00 target price on shares of Cognex in a research report on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $68.86.
Read Our Latest Stock Report on Cognex
Cognex Company Profile
(
Get Free Report)
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company's product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cognex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.
While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report